At a glance
ClinicalIndex Comparison RecordN/AWithdrawn· 0 enrolled
Drug / intervention
gene expression analysis +8 moregenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Biobehavioral Mechanisms of Fatigue in Patients Treated on NSABP B-45: A Phase III Clinical Trial Comparing Adjuvant Sunitinib Malate to Placebo in Women With Residual Invasive Breast Cancer Following Neoadjuvant Chemotherapy
In Brief
An observational study evaluating gene expression analysis, microarray analysis, and 7 other interventions for Breast Cancer and Fatigue. Withdrawn before enrollment.
Signals
Trial was withdrawn before enrollment
Detailed Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to fatigue. PURPOSE: This research study is looking at biological markers of fatigue in women with residual invasive breast cancer enrolled on clinical trial NSABP-B-45.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Fatigue
Countries--
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/AWithdrawnFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 2009
Primary CompletionJun 2010
TodayJul 2026
First PostedJun 4, 2009
Primary CompletionJun 1, 2010
TodayJul 1, 2026
Posted 17.1 years ago
Interventions
gene expression analysisgenetic
microarray analysisgenetic
polymerase chain reactiongenetic
polymorphism analysisgenetic
reverse transcriptase-polymerase chain reactiongenetic
biologic sample preservation procedureother
enzyme-linked immunosorbent assayother
laboratory biomarker analysisother
fatigue assessment and managementprocedure